SCHEMBL6938993

SCHEMBL6938993

NC(=O)[C@H](CC(=O)O)NNC(=O)NC(=O)c1cc(Cl)cc(Nc2ccccn2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 5/20 0.51
ITGAV P06756 5/20 0.51
RAB9A P51151 4/20 0.39
PKM P14618 2/20 0.39
ITGA2B P08514 1/20 0.35
NPC1 O15118 3/20 0.34
JAK2 O60674 2/20 0.34
JAK1 P23458 1/20 0.34
TYK2 P29597 1/20 0.34
JAK3 P52333 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GRM5 P41594 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
XIAP P98170 1/20 0.34
BIRC2 Q13490 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6941043 0.74 ITGB3 (0.54) ITGB3ITGAVITGA2B
SCHEMBL6937435 0.73 ITGB3 (0.51) ITGB3ITGAVRAB9APKMNPC1
SCHEMBL6934969 0.70 ITGB3 (0.51) ITGB3ITGAVRAB9AITGA2BNPC1
SCHEMBL7100373 0.68 ITGB3 (1.00) ITGB3ITGAVITGA2B
SCHEMBL6935372 0.68 NPC1 (0.38) ITGB3ITGAVRAB9AITGA2BNPC1
SCHEMBL6941352 0.67 ITGB3 (0.47) ITGB3ITGAVITGA2BSMN1; SMN2
SCHEMBL7879691 0.66 ITGB3 (0.56) ITGB3ITGAVRAB9AITGA2BNPC1
SCHEMBL28056305 0.66 MEN1 (0.53) ITGB3ITGAVRAB9ANPC1JAK2
SCHEMBL7882801 0.62 ALDH1A1 (0.41) ITGB3ITGAVKDM4EMAPTNPSR1
SCHEMBL6941874 0.61 PYGL (0.42) RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097127-B1 DIACYLHYDRAZINE DERIVATIVES AS INTEGRIN INHIBITORS MERCK PATENT GMBH (DE) 2003-03-12 EP disclosed
US-6326403-B1 CARDIOVASCULAR DISORDERS MERCK PATENT GESELLSCHAFT MIT (DE) 2001-12-04 US disclosed